Doyle Mittie
CIK 1918845
Transactions on file
30
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 2026-08-28 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 679 | $13.6K | -3.8% | open → |
| 2026-09-01 | 2026-08-28 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 679 | $5.5K | +139.2% | open → |
| 2026-08-19 | 2026-08-17 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 1,000 | $20.0K | -3.8% | open → |
| 2026-08-19 | 2026-08-17 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 1,000 | $12.7K | +52.0% | open → |
| 2026-08-12 | 2026-08-10 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 679 | $13.6K | -3.8% | open → |
| 2026-08-12 | 2026-08-10 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 679 | $5.5K | +139.2% | open → |
| 2026-07-29 | 2026-07-27 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 1,000 | $20.0K | -3.8% | open → |
| 2026-07-29 | 2026-07-27 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 1,000 | $12.7K | +52.0% | open → |
| 2026-07-02 | 2026-06-30 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 4,654 | $93.1K | -3.8% | open → |
| 2026-07-02 | 2026-06-30 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 1,779 | $14.3K | +139.2% | open → |
| 2026-07-02 | 2026-06-30 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 2,875 | $36.4K | +52.0% | open → |
| 2026-06-25 | 2026-06-23 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 1,450 | $26.1K | +6.8% | open → |
| 2026-06-25 | 2026-06-23 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 1,450 | $11.7K | +139.2% | open → |
| 2026-06-12 | 2026-06-10 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Tax | 1,084 | $14.2K | +46.8% | open → |
| 2026-06-01 | 2026-05-28 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 679 | $10.9K | +20.2% | open → |
| 2026-06-01 | 2026-05-28 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 679 | $5.5K | +139.2% | open → |
| 2026-05-26 | 2026-05-21 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Grant | 43,500 | $0.00 | — | open → |
| 2026-05-19 | 2026-05-15 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 3,000 | $56.3K | +2.5% | open → |
| 2026-05-19 | 2026-05-15 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 3,000 | $38.0K | +52.0% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 10,058 | $230.1K | -16.0% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 19,015 | $426.1K | -14.2% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 44,944 | $952.7K | -9.3% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 5,000 | $98.3K | -2.1% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 27,538 | $496.4K | +6.7% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 28,650 | $230.3K | +139.2% | open → |
| 2026-05-07 | 2026-05-06 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 77,905 | $985.5K | +52.0% | open → |
| 2026-05-07 | 2026-05-05 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale | 1,679 | $26.9K | +20.2% | open → |
| 2026-05-07 | 2026-05-05 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 679 | $5.5K | +139.2% | open → |
| 2026-05-07 | 2026-05-05 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Exer. | 1,000 | $12.7K | +52.0% | open → |
| 2025-12-12 | 2025-12-10 | AVTX Avalo Therapeutics, Inc. | Officer Chief Medical Officer | Tax | 1,013 | $4.2K | +369.0% | open → |
